Literature DB >> 7419006

Release of pancreatic polypeptide in humans by infusion of cholecystokinin.

J Lonovics, S Guzman, P Devitt, K E Hejtmancik, R L Suddith, P L Rayford, J C Thompson.   

Abstract

Plasma levels of pancreatic polypeptide were measured after a test meal and after infusion of graded doses of 99% pure cholecystokinin in 6 healthy volunteers. Initial attempts at sterilization of 99% pure cholecystokinin resulted in complete inactivation. Successful sterilization was accomplished by filtration by using specially treated silver-coated filters. Biologic activity of sterilized material was confirmed with cholecystokinin bioassay, and plasma levels of sterilized cholecystokinin achieved by exogenous infusions were measured with a specific cholecystokinin radioimmunoassay. Significant increases in plasma levels of pancreatic polypeptide were found with a test meal and with infusions of 0.25 and 0.5 micrograms/kg-hr of 99% pure cholecystokinin. Integrated values of pancreatic polypeptide released by the low-dose and the high-dose infusions of 99% pure cholecystokinin were 59% and 50% of that obtained by food, respectively. Integrated levels of cholecystokinin after 45 min of infusion of 0.25 micrograms/kg-hr were equal to those after a standard meal. Cholecystokinin, therefore, is an effective humoral releaser of pancreatic polypeptide in humans and may play an important role in the intestinal phase of release of pancreatic polypeptide.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7419006

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  25 in total

Review 1.  Biliary motility.

Authors:  P A Grace; G J Poston; R C Williamson
Journal:  Gut       Date:  1990-05       Impact factor: 23.059

Review 2.  Neural regulation of the endocrine pancreas.

Authors:  F C Brunicardi; D M Shavelle; D K Andersen
Journal:  Int J Pancreatol       Date:  1995-12

3.  Species-specific effects of neurotensin on gallbladder contraction in vitro.

Authors:  Y S Guo; P Singh; J R Upp; J C Thompson
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

4.  Role of cholecystokinin in bombesin- and meal-stimulated pancreatic polypeptide secretion in dogs.

Authors:  J B Jansen; A J de Jong; M V Singer; W Niebel; L C Rovati; C B Lamers
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

5.  Diagnostic role of gastrointestinal hormones in patients with chronic pancreatitis.

Authors:  W H Nealon; R D Beauchamp; C M Townsend; G Boyd; M Shabot; J C Thompson
Journal:  Ann Surg       Date:  1986-10       Impact factor: 12.969

6.  Experimental evidence for a vagally mediated and cholecystokinin-independent enteropancreatic reflex.

Authors:  G M Fried; W D Ogden; T Sakamoto; G H Greeley; J C Thompson
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

7.  Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones.

Authors:  J R Upp; W H Nealon; P Singh; C J Fagan; A S Jonas; G H Greeley; J C Thompson
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

8.  Release of cholecystokinin in man: correlation of blood levels with gallbladder contraction.

Authors:  I Wiener; K Inoue; C J Fagan; P Lilja; L C Watson; J C Thompson
Journal:  Ann Surg       Date:  1981-09       Impact factor: 12.969

9.  CCK receptors in release of pancreatic polypeptide (PP) in dogs.

Authors:  S J Konturek; P Konturek; W Bielański; K Szewczyk
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

10.  Comparative study of plasma pancreatic polypeptide responses to food, secretin, and bombesin in normal subjects and in patients with chronic pancreatitis.

Authors:  C B Lamers; C M Diemel; J B Jansen
Journal:  Dig Dis Sci       Date:  1984-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.